Publication

Preliminary data on safety, cellular kinetics and anti-leukemic activity of UCART19, an allogeneic Anti-CD19 CAR T-Cell product, in a pool of adult and pediatric patients with high-risk CD19+relapsed/refractory B-Cell acute lymphoblastic leukemia

Benjamin, R
; 
Graham, C
; 
Yallop, D
; 
Jozwik, A
; 
Ciocarlie, O
; 
Jain, N
; 
Jabbour, J
; 
Maus, V
; 
Frigault, M
; 
Boissel, N
... show 10 more
Citations
Altmetric:
Abstract
Authors
Benjamin, R
Graham, C
Yallop, D
Jozwik, A
Ciocarlie, O
Jain, N
Jabbour, J
Maus, V
Frigault, M
Boissel, N
Larghero, J
Baruchel, A
Mohty, M
De Moerloose, B
Bloor, Adrian
Frey, V
Zinai, A
Balandraud, S
Philippe, A
Fouliard, S
Gauthier, L
Pauly, J
Konto, C
Bermingham, C
Veys, P
Qasim, W
Affiliation
University of Leeds, Leeds Institute of Cancer and Pathology, Leeds
Description
Date
2018
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Benjamin R, Graham C, Yallop D, Jozwik A, Ciocarlie O, Jain N, et al. Preliminary data on safety, cellular kinetics and anti-leukemic activity of UCART19, an allogeneic Anti-CD19 CAR T-Cell product, in a pool of adult and pediatric patients with high-risk CD19+relapsed/refractory B-Cell acute lymphoblastic leukemia. Blood. 2018;132.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/621660
Embedded videos